HFS
DNA icon

Hantz Financial Services’s Ginkgo Bioworks DNA Stock Holding History

Hantz Financial Services’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-5
Closed – – 1096
2024
Q2 		$0 Sell
5
-6
-55% -$179 ﹤0.01% 1095
2024
Q1 		$1K Buy
11
+1
+10% +$52 ﹤0.01% 1109
2023
Q4 		$1K Hold
10
– – ﹤0.01% 1068
2023
Q3 		$1K Hold
10
– – ﹤0.01% 1063
2023
Q2 		$1K Hold
10
– – ﹤0.01% 1028
2023
Q1 		$1K Hold
10
– – ﹤0.01% 1046
2022
Q4 		$1K Buy
10
+5
+100% +$460 ﹤0.01% 1014
2022
Q3 		$1K Buy
+5
New +$596 ﹤0.01% 1009

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Hantz Financial Services's DNA Position: Q3 2024 in Review

Hantz Financial Services sold out of Ginkgo Bioworks (DNA) in Q3 2024, closing a stake of 5 shares.

Hantz Financial Services first reported a position in DNA in Q3 2022 and held it in 8 quarters. The position peaked at $1K in Q1 2024. 159 funds tracked by Wall St. Rank hold DNA as of Q3 2024.

  • Hantz Financial Services reported no remaining Ginkgo Bioworks position as of Q3 2024 after selling out during the quarter.
  • Hantz Financial Services sold 5 Ginkgo Bioworks shares in Q3 2024.
  • Hantz Financial Services first reported a position in Ginkgo Bioworks in Q3 2022 and held it in 8 quarters.
  • Hantz Financial Services's Ginkgo Bioworks position peaked at $1K in Q1 2024.
  • 159 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2024.

Based on Hantz Financial Services's 13F filing for Q3 2024, filed 14 Nov 2024.